35 related articles for article (PubMed ID: 18060687)
1. Fractalkine/CX3CL1 in Neoplastic Processes.
Korbecki J; Simińska D; Kojder K; Grochans S; Gutowska I; Chlubek D; Baranowska-Bosiacka I
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32466280
[TBL] [Abstract][Full Text] [Related]
2. CX3CL1 Signaling in the Tumor Microenvironment.
Conroy MJ; Lysaght J
Adv Exp Med Biol; 2020; 1231():1-12. PubMed ID: 32060841
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of lymphoid tissue from rhesus macaque rhadinovirus-infected monkeys identifies alterations in host genes associated with oncogenesis.
Estep RD; Govindan AN; Manoharan M; Li H; Fei SS; Park BS; Axthelm MK; Wong SW
PLoS One; 2020; 15(2):e0228484. PubMed ID: 32017809
[TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of CD11b
Yhim HY; Kim JA; Ko SH; Park Y; Yim E; Kim HS; Kwak JY
Oncotarget; 2017 Nov; 8(54):92289-92299. PubMed ID: 29190915
[TBL] [Abstract][Full Text] [Related]
5. The role of G protein-coupled receptors in lymphoid malignancies.
Nugent A; Proia RL
Cell Signal; 2017 Nov; 39():95-107. PubMed ID: 28802842
[TBL] [Abstract][Full Text] [Related]
6. Baicalin exerts protective effects against lipopolysaccharide-induced acute lung injury by regulating the crosstalk between the CX3CL1-CX3CR1 axis and NF-κB pathway in CX3CL1-knockout mice.
Ding XM; Pan L; Wang Y; Xu QZ
Int J Mol Med; 2016 Mar; 37(3):703-15. PubMed ID: 26782291
[TBL] [Abstract][Full Text] [Related]
7. Role of fractalkine/CX3CL1 and its receptor in the pathogenesis of inflammatory and malignant diseases with emphasis on B cell malignancies.
Ferretti E; Pistoia V; Corcione A
Mediators Inflamm; 2014; 2014():480941. PubMed ID: 24799766
[TBL] [Abstract][Full Text] [Related]
8. SOX11 expression correlates to promoter methylation and regulates tumor growth in hematopoietic malignancies.
Gustavsson E; Sernbo S; Andersson E; Brennan DJ; Dictor M; Jerkeman M; Borrebaeck CA; Ek S
Mol Cancer; 2010 Jul; 9():187. PubMed ID: 20624318
[TBL] [Abstract][Full Text] [Related]
9. CX3CR1 is expressed by human B lymphocytes and mediates [corrected] CX3CL1 driven chemotaxis of tonsil centrocytes.
Corcione A; Ferretti E; Bertolotto M; Fais F; Raffaghello L; Gregorio A; Tenca C; Ottonello L; Gambini C; Furtado G; Lira S; Pistoia V
PLoS One; 2009 Dec; 4(12):e8485. PubMed ID: 20041188
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and prognostic significance of gene expression profiling in lymphomas.
Leich E; Hartmann EM; Burek C; Ott G; Rosenwald A
APMIS; 2007 Oct; 115(10):1135-46. PubMed ID: 18042147
[TBL] [Abstract][Full Text] [Related]
11. Role of CX3CR1/CX3CL1 axis in primary and secondary involvement of the nervous system by cancer.
Marchesi F; Locatelli M; Solinas G; Erreni M; Allavena P; Mantovani A
J Neuroimmunol; 2010 Jul; 224(1-2):39-44. PubMed ID: 20630606
[TBL] [Abstract][Full Text] [Related]
12. B cell lymphomas express CX3CR1 a non-B cell lineage adhesion molecule.
Andréasson U; Ek S; Merz H; Rosenquist R; Andersen N; Jerkeman M; Dictor M; Borrebaeck CA
Cancer Lett; 2008 Feb; 259(2):138-45. PubMed ID: 18060687
[TBL] [Abstract][Full Text] [Related]
13. Mantle cell lymphomas express a distinct genetic signature affecting lymphocyte trafficking and growth regulation as compared with subpopulations of normal human B cells.
Ek S; Högerkorp CM; Dictor M; Ehinger M; Borrebaeck CA
Cancer Res; 2002 Aug; 62(15):4398-405. PubMed ID: 12154046
[TBL] [Abstract][Full Text] [Related]
14. Cytokine gene expression in neoplastic B cells from human mantle cell, follicular, and marginal zone lymphomas and in their postulated normal counterparts.
Airoldi I; Guglielmino R; Ghiotto F; Corcione A; Facchetti P; Truini M; Pistoia V
Cancer Res; 2001 Feb; 61(4):1285-90. PubMed ID: 11245421
[TBL] [Abstract][Full Text] [Related]
15. The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomas.
Paterson JC; Tedoldi S; Craxton A; Jones M; Hansmann ML; Collins G; Roberton H; Natkunam Y; Pileri S; Campo E; Clark EA; Mason DY; Marafioti T
Haematologica; 2006 Jun; 91(6):772-80. PubMed ID: 16769579
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
